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Whole-Genome Analysis of 60 G Protein-Coupled
Receptors in Caenorhabditis elegans by
Gene Knockout with RNAi
Results and Discussion
Candidate rhodopsin-like GPCRs, predicted to bind ei-
ther small-molecule neurotransmitters or neuropeptides,
were identified from the C. elegans genome database
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by using the Lymnaea stagnalis neuropeptide-activatedUniversity of Sussex
GPCR lymnokinin [6] as a search query (Figure 1). InFalmer
two strains, the functional role of the GPCRs was as-East Sussex
sessed by double-stranded RNA gene interferenceBN1 9QG
(RNAi) [7, 8] by using bacteria that express double-2 Cell Sciences Division
stranded RNA (dsRNA) as food for both wild-type ani-School of Biological Sciences
mals [9, 10], and this process was repeated with theUniversity of Southampton
RNAi-hypersensitive strain rrf-3 (pk1426) [11]. We as-Bassett Crescent East
sayed RNAi-treated animals for defects in locomotion,Southampton
the rate of egg laying, and brood size. The rationale wasHampshire SO16 7PX
to determine the physiological importance of GPCRs in3 Genome Damage and Stability Centre
diverse neural circuits for which these are the behavioralUniversity of Sussex
end points.Falmer
RNAi on N2 resulted in several uncoordinated (unc)East Sussex BN1 9QG
phenotypes that ranged from mild to relatively severe.4 Genetix
The more subtle phenotypes were observed for AC7.1New Milton
(mild sluggishness), T05A1.1 (flat wave form in the ante-Hampshire BH25 5NN
rior third of the animal, leading to a “kinked” appearanceUnited Kingdom
and periods of immobility), T02E9.1 (slowish motion;
increase in circular movement), C15B12.5 (sluggish),
C24A8.4 (increased head raising, slightly slow), and
F15A8.5 (slower anterior, poor reversal, poor touch re-Summary
sponse). The most severe phenotypes were observed
for C10C6.2 (slow motion, some animals paralyzed) andG protein-coupled receptors (GPCRs) are the largest
F59D12.1 (animals appeared slow and paralyzed).
family of genes in animal genomes and represent more
In order to confirm and quantify these behaviors, we
than 2% of genes in humans and C. elegans. These
repeated the experiments and counted body bends/min
evolutionarily conserved seven-transmembrane pro- and body wave amplitudes. RNAi resulted in a reproduc-
teins transduce a diverse range of signals. In view of ible and statistically significant effect on locomotion for
their pivotal role in cell signaling, it is perhaps surpris- seven genes (Figures 2A–2C). A reduction in body wave
ing that decades of genetic analysis in C. elegans, and amplitude was observed for three of these genes
recent genome-wide RNAi screens, have identified (C10C6.2, F59D12.1, and T02E9.1). Both RNAi and gene
very few GPCR mutants [1, 2]. Therefore, we screened deletion for T05A1.1 (XA3702) resulted in the same phe-
all GPCRs predicted to bind either small-molecule notype, consisting of alternating prolonged periods of
neurotransmitters or neuropeptides by using RNAi arrest with a flat wave form in the anterior and a short
and quantitative behavioral assays. This shows that period of motion with normal wave form. This was quan-
C16D6.2, C25G6.5, C26F1.6, F35G8.1, F41E7.3, and tified as a statistically significant reduction in body
F59C12.2 are likely to be involved in reproduction, bends in the gene deletion mutant (Figure 2D). We re-
whereas C15B12.5, C10C6.2, C24A8.4, F15A8.5, screened these sixty GPCRs by RNAi in rrf-3 but did not
F59D12.1, T02E9.1, and T05A1.1 have a role in locomo- identify any additional uncs in this RNAi hypersensitive
tion. Gene deletions for F35G8.1 and T05A1.1 resulted strain. This rather counterintuitive result may indicate
in the same phenotype as that seen with RNAi. As that the sensitivity of the rrf-3 mutant to RNAi is depen-
some GPCRs may be resistant to RNAi, or may result dent on the gene family targeted.
in abnormalities not screened for here, the actual pro- The effect of RNAi for these GPCRs on C. elegans
portion of nonredundant receptors with an assayable wave form and coordination may involve a number of
function is probably greater. Strikingly, most pheno- different mechanisms, e.g., RNAi could affect expres-
types were observed for NPY-like receptors that may sion of postsynaptic receptors in the somatic muscle.
Alternatively, the effect could be mediated indirectlybind neuropeptides. This is consistent with the known
through sensory and motor circuits involving interneu-actions of neuropeptides on the body wall muscle and
rons such as the AVA and AVE neurons, or motorneuronsreproductive tract in nematodes [3–5].
[12]. The most severe phenotype was observed follow-
ing RNAi for C10C6.2. Animals exhibited a flat wave form
(Figures 3A and 3B). As RNAi for C10C6.2 resulted in*Correspondence: lmhd@soton.ac.uk
5 These authors contributed equally to this work. such a marked impairment of locomotion, we hypothe-
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Figure 1. Phylogenetic Analysis of Receptors
Amino acid sequences lacking the N- and C-terminal regions of each protein were aligned by using ClustalW alignment methods (MegAlign).
Phylogenetic trees were constructed from these alignments. The phylogenetic analysis identified GPCRs that are putative receptors for small-
molecule transmitters or neuropeptides. Members of one subfamily of receptors (AH9.1, C03G6.16, F21C10.9, K10C8.2, R12C12.3, T19F4.1)
show a high level of identity to each other but are not closely related to any of the other families and are not shown here, and three additional
receptors (C26F1.6, F53A9.5; F53B7.2) did not align with any family. C. elegans receptors are shown in bold. Receptors for which RNAi resulted
in a phenotype in this study are shown in red. Key: D3-R, (human) dopamine type 3 receptor; P35462; A2A-R, (cuckoo wrasse) 2 adrenoreceptor;
Q91081; D1-R, (human) dopamine type 1 receptor; P21728; A1A-R, (human)  1 adrenoreceptor; P25100; O1-R, (Lymnaea stagnalis) octopamine
type 1 receptor; O77408; D2-R, (Drosophila) dopamine type 2 receptor; Q24563; 5HT2-R, (mouse) 5HT2 type 2 receptor; P35363; O2-R,
(Lymnaea stagnalis) octopamine type 2 receptor; O01670; 5HT1-R, (rat) 5HT2 type 1b receptor; P28564; 5HT1-R, (human) 5HT2 type 1d receptor;
P28221; T1-R, (Locusta) tyramine type 1 receptor; Q25321; M1-R, (human) muscarinic type 1 receptor; P11229; M2-R, (chicken) muscarinic
type 2 receptor; P30372; M3-R, (rat) muscarinic type 3 receptor; P08483; M4-R, (chicken) muscarinic type 4 receptor; P17200; M5-R, (rat)
muscarinic type 5 receptor; P08911; MTN-R, (human) melatonin type 1b receptor; P49286; CB1-R, (fish) cannabinoid type 1a receptor; Q98894;
AD1-R, (chicken) adenosine type a1 receptor; P49892; AD3-R, (rat) adenosine type a3 receptor; P28647; NY1-R (c), (human) NY1-R; P25929;
NY2-R(a), (human) NY2-R; P49146; NY2-R (b), (chicken) NY2-R, Q9ddn6; NY6-R (d), (mouse) NY6-R, Q61212; NY4-R (e), (human) NY4-R,
P50391; Alst-R, allostatin receptor (Periplaneta americana) AAK52473; Gal1-R, galanin receptor type 1 (mouse), P56479; Gal2-R, galanin
receptor type 2 (rat), O08726; Gal3-R, galanin receptor type 3 (rat), O88626; d-opioid-R, delta-type opioid receptor (human), P41143; k-opioid-
R, kappa-type opioid receptor (rat), P34975; Som1-R, somatostatin 1-R (rat), P28646; Som2-R, somatostain 2-R (bovine), P34993; CCK-R
P70031, (African clawed frog) cholecystokinin receptor; CCKa-R P30551, (rat) cholecystokinin type a receptor; Gastrin/CCK-R P32239, (human)
gastrin/cholecystokinin type b receptor; Vasopressin1a-R P37288, (human) vasopressin v1a receptor (v1ar); Oxytocin receptor P32306, (pig)
oxytocin receptor; Vasopressin2-R P30518, (human) vasopressin v2 receptor GnRH O42329 (African catfish), Gonadotrophin releasing hormone;
NTR1, neurotensin type 1 receptor (rat), P20789; NTR2, neurotensin type 2 receptor (human), O95665; GHS1, Growth hormone secretagogue
receptor type 1 (human), Q92847; TRH-R(bovine), Thyrotrophin releasing hormone receptor, O46639; TRH-R, (rat) Thyrotrophin releasing
hormone receptor, Q01717; Oxr, Orexin Receptor type 2 (rat), P56719; NPFF2, Neuropeptide FF type 2 receptor (human), Q9y5x5; Nka,
Neurokinin type a receptor (guinea pig), Q64077; NKb, Neurokinin type b receptor (mouse), P47937; Lkn, Lymnokinin receptor (Lymnaea
stagnalis), AAD118110; GRL106, cardioexcitatory peptide receptor (Lymnaea stagnalis), AAB92258.
sized that it may be expressed either in the body wall may explain the severe abnormality in locomotion fol-
lowing RNAi.muscle or extensively in the motor-nervous system. To
test this, we made a DsRed2 reporter construct for Of the seven genes for which RNAi gave an unc pheno-
type, three are predicted to bind neuropeptides and fourC10C6.2. In some experiments, we coinjected a pan-
neuronal GFP reporter construct so that we could more are predicted to be receptors for small molecules. Of
the latter, F15A8.5 has been confirmed as a dopamineaccurately define the extent of neuronal expression.
C10C6.2 was not expressed in body wall muscle. How- receptor [13]. Phylogenetic analysis predicts the others
to be receptors for dopamine (C24A8.4), melatoninever, it was extensively expressed in the ventral nerve
cord and appeared to be expressed in every neuron that (F59D12.1), and acetylcholine (C15B12.5). Of the neuro-
peptide receptors, one is a somatostatin- or galanin-had its cell body in this region of the animal, i.e., both
excitatory and inhibitory motorneurons (Figures 3C and like (T02E9.1) receptor, and two are NPY-like receptors
(C10C6.2 and T05A1.1).3D). This widespread expression pattern in the motor-
nervous system may indicate that this receptor acts as Screening 60 GPCRs by RNAi also identified receptors
that may have a role in reproduction. C. elegans lays aa universal “gain control” to increase locomotion and
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Figure 2. The Effect of RNAi on Locomotion
RNAi experiments were carried out as de-
scribed in [1]. Adult animals were phenotyped
at 72–120 hr post-L4 stage for defects in loco-
motion. Animal movement was assayed ei-
ther on RNAi plates in areas of low food, or
they were moved onto new plates with no
food.
(A) Locomotion was quantified by counting
the number of complete body bends (i.e.,
crest to new crest, of a sine wave) an animal
made during one minute.
(B) Body wave amplitude was calculated by
measuring the amplitude of a body sine wave
by using a graticule. The average of two or
more measurements was taken for each ani-
mal. Either a zero IPTG or empty vector con-
trol was conducted in parallel for each gene
tested. The bar graphs show the control data
(open bars) and RNAi data (filled bars) as a
mean  SE of the mean. Three or more inde-
pendent experiments were carried out for
each group, and the number of animals tested
is indicated by each bar. Each experiment
was repeated independently at least once for
each gene in a “blind” trial.
(C and D) A comparison of the (C) effect of
RNAi and (D) gene deletion for T05A1.1. Body
bends were counted during a period of 5 min.
Empty vector plus 1 mM IPTG is the control
for the RNAi experiment in (C). Data are the
mean  SE of the mean, n  8 animals. Wild-
type (N2) is the control for the gene deletion
mutant T05A1.1 in (D). Data are the mean 
SE of the mean, n  15. The deletion mutant
(XA3702, ok419IV) resulted in an in-frame-de-
letion removing residues 230–394 and was
out-crossed ten times prior to the assay. The
statistical significance was tested by using an
unpaired Student’s t test and the respective
parallel control for each gene; *P 0.05, **P
0.01, ***P  0.001.
characteristic number of eggs in an episodic pattern 48 hr could be due to a number of different possible
sites of action of the RNAi, e.g., there could be effectsduring its life cycle [14]. Upon reaching adulthood, all
of the eggs (approximately 300) are laid within approxi- on fertilization, embryogenesis, or the rate of egg laying.
To assess these RNAi effects in more detail, we repeatedmately 3 days (at 20C). Therefore, as a first, quick assay,
we counted the total number of progeny (embryos and the RNAi experiments and counted the number of eggs
laid at approximately eight hourly intervals post-L4.larvae) produced by RNAi-treated animals at 48 hr post-
L4 larval stage. RNAi for three genes (F59C12.2, RNAi in N2 animals for F59C12.2, F35G8.1, and C26F1.6
increased the rate of egg laying and brood size (FigureF35G8.1, C26F1.6) in N2 animals resulted in a statisti-
cally significant increase (P  0.05) in the number of 4A), whereas RNAi in rrf-3 animals for C16D6.2,
C25G6.5, and F41E7.3 decreased the rate of egg layingprogeny counted at 48 hr post-L4, whereas RNAi for
C16D6.2 resulted in a significant decrease. (Figure 4B). These data are consistent with and confirm
the results we obtained in the earlier screen that countedRescreening these 60 GPCRs by RNAi in rrf-3 animals
replicated the result of a decreased number of progeny progeny at 48 hr post-L4. A gene deletion mutant for
F35G8.1 also resulted in an increase in the rate of eggat 48 hr for C16D6.2 and revealed a similar phenotype
for two additional genes, C25G6.5 and F41E7.3 (data laying and a slight increase in brood size (Figure 4C).
This mutant lays eggs faster than wild-type during thenot shown). Interestingly, however, in view of the fact
that rrf-3 itself has the phenotype of temperature-sensi- first 2 days following the L4/adult molt (wild-type rate:
5.33  0.29 eggs/hr, compared to 6.90  0.03 eggs/hrtive sterility [11], the screen with rrf-3 animals did not
replicate the phenotype of an increase in the number of in F35G8.1, between 24 and 48 hr after the L4 molt).
However, a gene deletion mutant for C25G6.5 (XA3700)progeny at 48 hr that was observed for wild-type animals
treated with RNAi for F59C12.2, F35G8.1, or C26F1.6 did not replicate the RNAi-induced reduction in egg lay-
ing observed with rrf-3 when assayed at 20C, but it(data not shown). This suggests that in an rrf-3 back-
ground, the effect of RNAi for F59C12.2, F35G8.1, and instead showed the opposite effect of a significant in-
crease in the rate of egg laying at 15C (data not shown).C26F1.6 on egg-laying rate is suppressed.
These effects of RNAi on the numbers of progeny at The reason for this inconsistency is still not clear but
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Figure 3. The Role of C10C6.2 in Locomotion
(A and B) A comparison of wave form in (A)
wild-type and (B) animals treated with RNAi
for C10C6.2. Note the flattened wave form in
the RNAi-treated animal.
(C) The expression pattern of C10C6.2 was
determined by using a C10C6.2::DsRed2 re-
porter construct containing 1965 nucleotides
of the 5 flanking region and 658 nucleotides
of the C10C6.2 coding sequence in frame
with DsRed2.
(D) This construct was coinjected with pCel-
ica-P-GFP for pan-neuronal expression of a
Ric-19-GFP fusion protein [26].
(C) and (D) are images of the same animal
that indicate that C10C6.2 is expressed in all
of the neurons of the ventral nerve cord. The
position of the nerve cord is indicated by the
arrows.
may indicate an interaction between this GPCR and obtained in this study, this indicates that at least 15
members of this GPCR family have a discernible physio-RRF-3. Nevertheless, the result with C25G6.5 confirms
that this gene plays a role in egg-laying rate. logical role. Most phenotypes were observed following
RNAi for NPY-like receptors. This may be due to aThe precise mechanism underlying these RNAi effects
on egg laying and brood size has not been determined greater susceptibility of these genes to RNAi, perhaps
by virtue of the cell types in which they are expressedhere. For example, there could be a change in the rate
of ovulation, the number of sperm in the spermatheca, or a short half-life of the receptor protein. Alternately, it
may be a genuine reflection of the importance of thismicrochanges in the worm’s anatomy, or indeed a physi-
ological change in the neurons or muscles that regulate family of receptors, relative to other GPCRs, in the con-
trol of egg laying and locomotion. Therefore, it is relevantegg laying. The egg-laying assay we have employed
does not distinguish between the effects on egg produc- to note that NPY-like receptors in other invertebrates are
activated by RFamide peptides [16] and that nematodetion and the more specific effects elicited through action
in the neuronal circuitry that regulates the rate of egg RFamide peptides have potent effects on reproductive
and body-wall muscle [3–5, 17–21]. Furthermore, alaying. Reduction in the rate of egg laying can be attrib-
uted to general malaise of the animal and a consequent gene knockout for flp-1, a C. elegans gene encoding
FMRFamide-like neuropeptides, results in hyperactivitydecrease in egg production, and this may underlie the
reduction in egg laying following RNAi for C16D6.2 and [22], and mutants defective in peptidergic signaling ex-
hibit several abnormalities, including defective locomo-F41E7.3. However, RNAi for three genes (F35G8.1,
C26F1.6, and F59C12.2) resulted in an increase in the tion, constitutive pharyngeal pumping, and defective
egg laying [23, 24]. The ligands for the receptors thatrate of egg laying; this increase indicates a more specific
effect on fecundity. exhibited RNAi phenotypes may therefore be some of
the many neuropeptides isolated, or predicted from, C.In conclusion, this study is the first systematic, func-
tional genomic screen to focus on GPCRs. Only four of elegans [25] that have been shown to have bioactivity
in the nematode enteric or motor-nervous systems.the genes that we studied here have previously been
allocated a phenotype. RNAi for one of the tachykinin- The utility of quantitative behavioral analysis and RNAi
in identifying functional roles for GPCRs holds the prom-like GPCRs, AC7.1, was reported to result in a “sick”
phenotype [1]. However, we observed only a slight, sta- ise that screens focusing on other behaviors (e.g., pha-
ryngeal pumping, osmotic avoidance, chemotaxis) willtistically insignificant slowing of locomotion. A recent
RNAi screen for fat deposition [2] allocated a phenotype enable further delineation of the physiological roles of
GPCRs in C. elegans. As far as other animals, includingto two additional genes (C38C10.1 and F56B6.5; de-
creased and increased fat deposition, respectively). In mammals, are concerned, the definition of the physio-
logical roles of orphan GPCRs, many predicted to bindaddition, mutation in the NPY-like receptor, C39E6.6,
alters social feeding [15]. Taken together with the results neuropeptides, is a biological problem of major impor-
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Figure 4. Gene Knockout for Six GPCRs Af-
fects the Rate of Egg Laying
(A) RNAi on wild-type animals.
(B) RNAi on the hypersensitive mutant rrf-3.
(C) The effect of a gene deletion for F35G8.1
(XA3701, ok527X). RNAi methods employed
were similar to those described in [1]. L4-
stage animals were transferred onto individ-
ual plates, with HT115 or OP50, and were
incubated at 15C (for rrf-3) or 20C (for N2).
The adult worms were repeatedly transferred
to fresh plates at intervals of approximately
8 hr. Plates with embryos were stored at 4C
for later counting. For the gene deletion mu-
tant, the assays were conducted in a similar
fashion but on NGM plates. These assays
were performed as randomized blind trials.
The data shown are the cumulative number
of eggs laid post-L4 (mean SE of the mean;
n  8). A 1 mM IPTG “empty” vector control
was conducted in parallel for each gene
tested in (A) and (B). The statistical signifi-
cance was tested by using an unpaired Stu-
dent’s t test and the respective parallel con-
trol for each gene; *P  0.05, **P  0.01,
***P  0.001.
Current Biology
1720
12. White, J.G., Southgate, E., Thomson, J.N., and Brenner, S.tance. This study shows that phenotypes can be de-
(1986). The structure of the nervous system of the nematodetected for C. elegans GPCRs knockouts and provides
Caenorhabditis elegans. Philos. Trans. R. Soc. Lond. B Biol.the opportunity to investigate the interrelationship of
Sci. 314, 1–340.
structurally and functionally related GPCRs in the con- 13. Suo, S., Sasagawa, N., and Ishiura, S. (2002). Identification of
text of the physiology of the entire animal. a dopamine receptor from Caenorhabditis elegans. Neurosci.
Lett. 319, 13–16.
Supplemental Data 14. Waggoner, L.E., Zhou, G.T., Schafer, R.W., and Schafer, W.R.
Supplemental Data including Experimental Procedures and a sum- (1998). Control of alternative behavioral states by serotonin in
mary table for the RNAi results for all the GPCRs studied here are Caenorhabditis elegans. Neuron 21, 203–214.
available at http://www.current-biology.com/cgi/content/full/13/19/ 15. de Bono, M., and Bargmann, C.I. (1998). Natural variation in a
1715/DC1/. neuropeptide Y receptor homolog modifies social behavior and
food response in C. elegans. Cell 94, 679–689.
16. Tensen, C.P., Cox, K., Smit, A.B., van der Schors, R.C., Meyer-Acknowledgments
hof, W., Richter, D., Planta, R.J., Hermann, P.M., van Minnen,
J., Geraerts, W.P., et al. (1998). The Lymnaea cardioexcitatoryThis study was funded by the Biotechnology and Biological Sci-
peptide (LyCep) receptor: a G-protein-coupled receptor for aences Research Council, UK. Some strains used in this work were
novel member of the RFamide neuropeptide family. J. Neurosci.provided by the C. elegans Genetics Center, which is funded by the
18, 9812–9821.National Center for Research Resources of the National Institutes
17. Holden-Dye, L., Franks, C.J., Williams, R.G., and Walker, R.J.of Health (NIH). We are grateful to Ben Pilkington for help with
(1995). The effect of the nematode peptides SDPNFLRFamideconfocal microscopy, Ralf Schnabel for pha-1, Marc Pilon for pCel-
(PF1) and SADPNFLRFamide (PF2) on synaptic transmissionica-P-GFP, and Craig Hunter for pHC183. We gratefully acknowl-
in the parasitic nematode Ascaris suum. Parasitology 110,edge receipt of gene deletion mutants from the C. elegans Gene
449–455.Knockout Consortium.
18. Pang, F.Y., Mason, J., Holden-Dye, L., Franks, C.J., Williams,
R.G., and Walker, R.J. (1995). The effects of the nematode pep-Received: February 24, 2003
tide, KHEYLRFamide (AF2), on the somatic musculature of theRevised: August 12, 2003
parasitic nematode Ascaris suum. Parasitology 110, 353–362.Accepted: August 15, 2003
19. Brownlee, D.J., Holden-Dye, L., and Walker, R.J. (2000). ThePublished: September 30, 2003
range and biological activity of FMRFamide-related peptides
and classical neurotransmitters in nematodes. Adv. Parasitol.References
45, 109–180.
20. Cowden, C., and Stretton, A.W. (1993). AF2, an Ascaris neuro-1. Kamath, R.S., Fraser, A.G., Dong, Y., Paulin, G., Durbin, R.,
peptide: isolation, sequence, and bioactivity. Peptides 14,Gotta, M., Kanapin, A., Le Bot, N., Moreno, S., Sohrmann, M., et
423–430.al. (2003). Systematic functional analysis of the Caenorhabditis
21. Rogers, C.M., Franks, C.J., Walker, R.J., Burke, J.F., andelegans genome using RNAi. Nature 421, 231–237.
Holden-Dye, L. (2001). Regulation of the pharynx of Caenorhab-2. Ashrafi, K., Chang, F.Y., Watts, J.L., Fraser, A.G., Kamath, R.S.,
ditis elegans by 5-HT, octopamine and FMRFamide-like neuro-Ahringer, J., and Ruvkun, G. (2003). Genome-wide RNAi analysis
peptides. J. Neurobiol. 49, 235–244.of Caenorhabditis elegans fat regulatory genes. Nature 421,
22. Nelson, L.S., Rosoff, M.L., and Li, C. (1998). Disruption of a268–272.
neuropeptide gene, flp-1, causes multiple behavioral defects in3. Cowden, C., Stretton, A.W., and Davis, R.E. (1989). AF1, a se-
Caenorhabditis elegans. Science 281, 1686–1690.quenced bioactive neuropeptide isolated from the nematode
23. Avery, L., Bargmann, C., and Horvitz, H. (1993). The Caenorhab-Ascaris suum. Neuron 2, 1465–1473.
ditis elegans unc-31 gene affects multiple nervous system-con-4. Holden-Dye, L., Brownlee, D.A., and Walker, R.J. (1997). The
trolled functions. Genetics 134, 454–464.effects of the peptide KPNFIRFamide (PF4) on the somatic mus-
24. Jacob, T.C., and Kaplan, J.M. (2003). The EGL-21 carboxypepti-cle cells of the parasitic nematode Ascaris suum. Br. J. Pharma-
dase E facilitates acetylcholine release at Caenorhabditis ele-col. 120, 379–386.
gans neuromuscular junctions. J. Neurosci. 23, 2122–2130.5. Fellowes, R.A., Maule, A.G., Marks, N.J., Geary, T.G., Thompson,
25. Nelson, L.S., Kim, K.Y., Memmott, R.E., and Li, C. (1998).D.P., Shaw, C., and Halton, D.W. (1998). Modulation of the motil-
FMRFamide-related gene family in the nematode, Caenorhab-ity of the vagina vera of Ascaris suum in vitro by FMRFamide-
ditis elegans. Mol. Brain Res. 58, 103–111.related peptides. Parasitology 116, 277–287.
26. Pilon, M., Peng, X.R., Spence, A.M., Plasterk, R.H., and Dosch,6. Cox, K.J., Tensen, C.P., Van der Schors, R.C., Li, K.W., Heerik-
H.M. (2000). The diabetes autoantigen ICA69 and its Caenorhab-huizen, H., Vreugdenhil, E., Geraerts, W.P., and Burke, J.F.
ditis elegans homologue, ric-19, are conserved regulators of(1997). Cloning, characterisation and expression of a G-protein-
neuroendocrine sectretion. Mol. Biol. Cell 10, 3277–3288.coupled receptor from Lymnaea stagnalis and identification of
a leucokinin-like peptide PSFHSWSamide, as its ligand. J. Neu-
rosci. 17, 1197–1205.
7. Fire, A. (1999). RNA-triggered gene silencing. Trends Genet. 15,
358–363.
8. Fraser, A., Kamath, R., Zipperlen, P., Martinez-Compos, M.,
Sohrmann, M., and Ahringer, J. (2000). Functional genomic anal-
ysis of C. elegans chromosome I by systematic RNA interfer-
ence. Nature 408, 325–330.
9. Timmons, L., and Fire, A. (1998). Specific interference by in-
gested dsRNA. Nature 395, 854.
10. Kamath, R.S., Martinez-Campos, M., Zipperlen, P., Fraser, A.G.,
and Ahringer, J. (2000). Effectiveness of specific RNA-mediated
interference through ingested double-stranded RNA in Caeno-
rhabditis elegans. Genome Biol. 2, 1–10.
11. Simmer, F., Tijsterman, M.P., Parrish, S., Koushika, S., Nonet,
M., Fire, A., Ahringer, J., and Plasterk, R.H. (2002). Loss of the
putative RNA-directed RNA polymerase RRF-3 makes C. ele-
gans hypersensitive to RNAi. Curr. Biol. 12, 1317–1319.
